Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Review Article

Protein Informatics and Vaccine Development: Cancer Case Study

Author(s): Saroj Verma, Neeraj Masand, Rameshwar S. Cheke and Vaishali M. Patil*

Volume 22, Issue 26, 2022

Published on: 15 November, 2022

Page: [2207 - 2220] Pages: 14

DOI: 10.2174/1568026623666221107160636

Price: $65

conference banner
Abstract

Clinical translation is a challenging step in the development of cancer vaccines and is found to be related to the complex nature of cancer immunology. Vaccine-based therapeutic strategies for cancer have gained consideration with the advent of vaccine technology as well as an understanding of cancer immunology. Immunotherapy has been widely used in the treatment of cancer. Some promising candidates have been identified to engineer cancer vaccines like Glycoprotein, Mucin 1, MHC protein, etc. It has benefited from the availability of advanced techniques for rapid identification and selection of proteins for precision engineering. Simultaneously, nanovaccines have been focused on target delivery and artificial intelligence-based approaches for personalized vaccine development. The manuscript summarizes the advances in the development of structurebased cancer vaccines along with the status of clinical studies and applications.

Keywords: Cancer vaccines, Immunotherapy, Structure-based vaccines, Personalized cancer vaccines, Clinical trials, Oncolytic vaccines, Nano vaccines.

« Previous
Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy